DK1265604T3 - Proces til udvinding af statinforbindelser fra en gæringsvæske - Google Patents

Proces til udvinding af statinforbindelser fra en gæringsvæske

Info

Publication number: DK1265604T3
Authority: DK; Denmark
Prior art keywords: extracting; statin compounds; fermentation fluid; fermentation; fluid
Prior art date: 1999-11-30

Application number

DK00980834T

Other languages

Danish (da)

English (en)

Inventor

Vilmos Keri

Lajos Deak

Ilona Forgacs

Csaba Szabo

Edit Arvai Nagyne

Original Assignee

Teva Gyogyszergyar Zartkoeruee

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-30

Filing date

2000-11-28

Publication date

2007-02-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22609918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1265604(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-11-28 Application filed by Teva Gyogyszergyar Zartkoeruee filed Critical Teva Gyogyszergyar Zartkoeruee

2007-02-05 Application granted granted Critical

2007-02-05 Publication of DK1265604T3 publication Critical patent/DK1265604T3/da

Links

229940121710 HMGCoA reductase inhibitor Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
238000000855 fermentation Methods 0.000 title 1
230000004151 fermentation Effects 0.000 title 1
239000012530 fluid Substances 0.000 title 1
238000000034 method Methods 0.000 title 1
TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 abstract 1
OQARDMYXSOFTLN-PZAWKZKUSA-N pravastatin lactone Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 OQARDMYXSOFTLN-PZAWKZKUSA-N 0.000 abstract 1
229960001495 pravastatin sodium Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Crystallography & Structural Chemistry (AREA)
Nanotechnology (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Manufacturing & Machinery (AREA)
Animal Behavior & Ethology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrane Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK00980834T 1999-11-30 2000-11-28 Proces til udvinding af statinforbindelser fra en gæringsvæske DK1265604T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16805699P	1999-11-30	1999-11-30
PCT/US2000/032391 WO2001039768A1 (en)	1999-11-30	2000-11-28	Process for recovering statin compounds from a fermentation broth

Publications (1)

Publication Number	Publication Date
DK1265604T3 true DK1265604T3 (da)	2007-02-05

Family

ID=22609918

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00980834T DK1265604T3 (da)	1999-11-30	2000-11-28	Proces til udvinding af statinforbindelser fra en gæringsvæske

Country Status (22)

Country	Link
US (3)	US6444452B1 (pl)
EP (1)	EP1265604B1 (pl)
JP (5)	JP3881240B2 (pl)
KR (1)	KR20030026920A (pl)
CN (2)	CN1433305A (pl)
AT (2)	ATE342717T1 (pl)
AU (1)	AU1804601A (pl)
CA (1)	CA2393057C (pl)
CY (1)	CY1105925T1 (pl)
DE (3)	DE04010770T1 (pl)
DK (1)	DK1265604T3 (pl)
ES (2)	ES2239937T1 (pl)
HR (1)	HRP20020454A2 (pl)
HU (1)	HUP0204012A3 (pl)
MX (1)	MXPA02005283A (pl)
PL (1)	PL364918A1 (pl)
PT (1)	PT1265604E (pl)
RU (1)	RU2002114072A (pl)
SK (1)	SK7342002A3 (pl)
WO (1)	WO2001039768A1 (pl)
YU (1)	YU39102A (pl)
ZA (1)	ZA200203912B (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7141602B2 (en) *	1998-09-18	2006-11-28	Lek Pharmaceuticals D.D.	Process for obtaining HMG-CoA reductase inhibitors of high purity
US6682913B1 (en) *	1999-02-03	2004-01-27	Institute For Drug Research Ltd.	Microbial process for preparing pravastatin
JP3881240B2 (ja) *	1999-11-30	2007-02-14	テバジョジセルジャールザ−トケルエンムケドレ−スベニュタ−ルシャシャ−グ	醗酵ブロスからスタチン化合物を回収するための方法
SK8312002A3 (en) *	1999-12-14	2003-05-02	Biogal Gyogyszergyar	Novel forms of pravastatin sodium
CN1468098A (zh) *	2000-10-05	2004-01-14	�ݰ¸Ƕ�ҩ��޹�˾	基本上无普伐他汀内酯和表普伐他汀的普伐他汀钠和包含普伐他汀钠的组合物
US20050215636A1 (en) *	2000-10-05	2005-09-29	Vilmos Keri	Pravastatin sodium substantially free of pravastatin lactone and EPI-pravastatin, and compositions containing same
JP2002121172A (ja) *	2000-10-16	2002-04-23	Sankyo Co Ltd	プラバスタチン又はその薬理上許容される塩の精製方法
DE10119718A1 (de) *	2001-04-21	2002-10-31	Boehringer Ingelheim Pharma	Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
JP2003026634A (ja) *	2001-07-17	2003-01-29	Mercian Corp	プラバスタチンナトリウム塩の製造方法
US6716615B2 (en)	2002-02-27	2004-04-06	Yung Shin Pharmaceutical Ind. Co., Ltd.	Strains of saccharaothrix, process for producing pravastatin using the strains and isolation process of (HMG)-CoA reductase
JP3422791B2 (ja)	2002-08-06	2003-06-30	三共株式会社	プラバスタチンの単離・精製方法
KR100540761B1 (ko) *	2002-08-09	2006-01-16	코바이오텍 (주)	프라바스타틴 나트륨의 제조방법
EP1477471A1 (en) *	2003-05-14	2004-11-17	Chunghwa Chemical Synthesis & Biotech Co., Ltd.	Process for purifying pravastin sodium from a fermentation broth
CA2546377A1 (en) *	2003-11-24	2005-06-09	Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag	Method of purifying pravastatin
RU2317991C1 (ru) *	2003-12-05	2008-02-27	Байокон Лимитид	Способ выделения и очистки макролидов
WO2006046130A2 (en) *	2004-10-29	2006-05-04	Ranbaxy Laboratories Limited	Process for the preparation of pravastatin
TW200640854A (en) *	2005-02-09	2006-12-01	Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag	Methods of making pravastatin sodium
JP4813841B2 (ja) *	2005-07-25	2011-11-09	キユーピー株式会社	プラバスタチンナトリウムの製造方法
DE102006028817A1 (de) *	2006-06-21	2007-12-27	Evonik Degussa Gmbh	Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen
WO2009078033A2 (en) *	2007-12-18	2009-06-25	Themis Medicare Limited	Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth
US20110130450A1 (en) *	2008-04-02	2011-06-02	Aad Johannes Bouman	Pravastatin extraction
IN2009MU00380A (pl) *	2009-02-18	2010-04-02
CN102993145B (zh) *	2011-09-19	2015-06-03	北大方正集团有限公司	一种提取纯化洛伐他汀的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4319039A (en) *	1979-06-15	1982-03-09	Merck & Co., Inc.	Preparation of ammonium salt of hypocholesteremic fermentation product
MX7065E (es) *	1980-06-06	1987-04-10	Sankyo Co	Un procedimiento microbiologico para preparar derivados de ml-236b
DE3682557D1 (de) *	1985-09-13	1992-01-02	Sankyo Co	Hydroxy-ml-236b-derivate, deren herstellung und anwendung.
US4857547A (en) *	1988-01-07	1989-08-15	Merck & Co., Inc.	Novel HMG-CoA reductase inhibitors
US4857522A (en) *	1988-03-21	1989-08-15	E. R. Squibb & Sons, Inc.	Derivatives of pravastatin for inhibiting cholesterol biosynthesis
US5180589A (en) *	1988-03-31	1993-01-19	E. R. Squibb & Sons, Inc.	Pravastatin pharmaceuatical compositions having good stability
US5099035A (en) *	1989-02-27	1992-03-24	E. R. Squibb & Sons, Inc.	Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5140012A (en) *	1990-05-31	1992-08-18	E. R. Squibb & Sons, Inc.	Method for preventing onset of restenosis after angioplasty employing pravastatin
US5202029A (en)	1991-03-13	1993-04-13	Caron Kabushiki Kaisha	Process for purification of hmg-coa reductase inhibitors
US5157025A (en) *	1991-04-01	1992-10-20	E. R. Squibb & Sons, Inc.	Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
NZ250609A (en) *	1992-12-28	1995-07-26	Sankyo Co	Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
SI9300303A (en)	1993-06-08	1994-12-31	Krka Tovarna Zdravil	Process for isolation of hypolipemic effective substance
US5616595A (en)	1995-06-07	1997-04-01	Abbott Laboratories	Process for recovering water insoluble compounds from a fermentation broth
US5942423A (en)	1995-06-07	1999-08-24	Massachusetts Institute Of Technology	Conversion of compactin to pravastatin by actinomadura
US5883109A (en) *	1996-07-24	1999-03-16	Bristol-Myers Squibb Company	Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
WO1998037220A1 (en) *	1997-02-20	1998-08-27	Dsm N.V.	Nitrogen feed in statin fermentation
AU9264598A (en)	1997-08-22	1999-03-16	Gist-Brocades B.V.	Statin production by fermentation
SI9800046A (sl) *	1998-02-18	1999-08-31	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
SI20072A (sl) *	1998-09-18	2000-04-30	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
SK10932001A3 (sk) *	1999-02-03	2002-06-04	Institute For Drug Research Ltd.	Mikrobiálny spôsob výroby pravastatínu
US6682913B1 (en) *	1999-02-03	2004-01-27	Institute For Drug Research Ltd.	Microbial process for preparing pravastatin
HUP9902352A1 (hu)	1999-07-12	2000-09-28	Gyógyszerkutató Intézet Kft.	Eljárás pravasztatin mikrobiológiai előállítására
JP3881240B2 (ja) *	1999-11-30	2007-02-14	テバジョジセルジャールザ−トケルエンムケドレ−スベニュタ−ルシャシャ−グ	醗酵ブロスからスタチン化合物を回収するための方法
CN1468098A (zh) *	2000-10-05	2004-01-14	�ݰ¸Ƕ�ҩ��޹�˾	基本上无普伐他汀内酯和表普伐他汀的普伐他汀钠和包含普伐他汀钠的组合物

2000
- 2000-11-28 JP JP2001541501A patent/JP3881240B2/ja not_active Expired - Fee Related
- 2000-11-28 CN CN00818725A patent/CN1433305A/zh active Pending
- 2000-11-28 WO PCT/US2000/032391 patent/WO2001039768A1/en not_active Ceased
- 2000-11-28 KR KR1020027006920A patent/KR20030026920A/ko not_active Abandoned
- 2000-11-28 CN CNA2005100739122A patent/CN1754872A/zh active Pending
- 2000-11-28 CA CA002393057A patent/CA2393057C/en not_active Expired - Fee Related
- 2000-11-28 HR HR20020454A patent/HRP20020454A2/xx not_active Application Discontinuation
- 2000-11-28 DE DE04010770T patent/DE04010770T1/de active Pending
- 2000-11-28 RU RU2002114072/13A patent/RU2002114072A/ru not_active Application Discontinuation
- 2000-11-28 AT AT00980834T patent/ATE342717T1/de not_active IP Right Cessation
- 2000-11-28 EP EP00980834A patent/EP1265604B1/en not_active Expired - Lifetime
- 2000-11-28 US US09/723,711 patent/US6444452B1/en not_active Expired - Fee Related
- 2000-11-28 PT PT00980834T patent/PT1265604E/pt unknown
- 2000-11-28 ES ES04010770T patent/ES2239937T1/es active Pending
- 2000-11-28 AT AT04010770T patent/ATE382344T1/de not_active IP Right Cessation
- 2000-11-28 YU YU39102A patent/YU39102A/sh unknown
- 2000-11-28 MX MXPA02005283A patent/MXPA02005283A/es unknown
- 2000-11-28 HU HU0204012A patent/HUP0204012A3/hu unknown
- 2000-11-28 DE DE60037687T patent/DE60037687D1/de not_active Expired - Lifetime
- 2000-11-28 PL PL00364918A patent/PL364918A1/pl unknown
- 2000-11-28 SK SK734-2002A patent/SK7342002A3/sk unknown
- 2000-11-28 DE DE60031447T patent/DE60031447T2/de not_active Expired - Fee Related
- 2000-11-28 AU AU18046/01A patent/AU1804601A/en not_active Abandoned
- 2000-11-28 ES ES00980834T patent/ES2273737T3/es not_active Expired - Lifetime
- 2000-11-28 DK DK00980834T patent/DK1265604T3/da active
2002
- 2002-05-16 ZA ZA200203912A patent/ZA200203912B/en unknown
- 2002-07-23 US US10/200,149 patent/US6689590B2/en not_active Expired - Fee Related
2003
- 2003-11-05 US US10/700,567 patent/US20040115781A1/en not_active Abandoned
2004
- 2004-07-13 JP JP2004206262A patent/JP2004350687A/ja active Pending
2005
- 2005-10-19 JP JP2005304900A patent/JP2006055174A/ja not_active Withdrawn
2006
- 2006-05-22 JP JP2006141646A patent/JP2006273861A/ja active Pending
2007
- 2007-01-15 CY CY20071100052T patent/CY1105925T1/el unknown
2008
- 2008-02-06 JP JP2008026632A patent/JP4343987B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2003515334A (ja)	2003-05-07
DE60037687D1 (de)	2008-02-14
AU1804601A (en)	2001-06-12
WO2001039768A1 (en)	2001-06-07
JP3881240B2 (ja)	2007-02-14
ATE382344T1 (de)	2008-01-15
ATE342717T1 (de)	2006-11-15
EP1265604B1 (en)	2006-10-18
US20020187531A1 (en)	2002-12-12
DE60031447T2 (de)	2007-08-30
ES2239937T1 (es)	2005-10-16
MXPA02005283A (es)	2003-10-06
PT1265604E (pt)	2006-12-29
EP1265604A4 (en)	2004-06-16
JP2008109948A (ja)	2008-05-15
EP1265604A1 (en)	2002-12-18
PL364918A1 (pl)	2004-12-27
HUP0204012A2 (hu)	2003-03-28
DE60031447D1 (de)	2006-11-30
JP2006273861A (ja)	2006-10-12
US6444452B1 (en)	2002-09-03
CA2393057A1 (en)	2001-06-07
KR20030026920A (ko)	2003-04-03
HUP0204012A3 (en)	2003-12-29
ZA200203912B (en)	2003-08-21
JP4343987B2 (ja)	2009-10-14
CA2393057C (en)	2008-01-29
HRP20020454A2 (en)	2005-10-31
CN1754872A (zh)	2006-04-05
RU2002114072A (ru)	2004-07-20
DE04010770T1 (de)	2005-10-20
YU39102A (sh)	2006-01-16
SK7342002A3 (en)	2004-03-02
CN1433305A (zh)	2003-07-30
JP2004350687A (ja)	2004-12-16
JP2006055174A (ja)	2006-03-02
ES2273737T3 (es)	2007-05-16
US6689590B2 (en)	2004-02-10
US20040115781A1 (en)	2004-06-17
CY1105925T1 (el)	2011-04-06

Publication	Publication Date	Title
DK1265604T3 (da)	2007-02-05	Proces til udvinding af statinforbindelser fra en gæringsvæske
EA199800290A1 (ru)	1998-10-29	(метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2
NO20020214D0 (no)	2002-01-15	Substituerte oksozaheterocyklylforbindelser
PT789578E (pt)	2003-10-31	Inibidores da protease multicatalitica
PE20020707A1 (es)	2002-08-11	Compuestos tripeptidicos como inhibidores de la proteasa ns3 del virus de hepatitis c
DE69516866D1 (de)	2000-06-15	Stereochemische wortmanninderivate
UY27362A1 (es)	2003-01-31	Métodos de usar inhibidores de epóxido hidrolasa soluble
DK0923554T3 (da)	2002-04-29	N-Benzylpiperidin- og tetrahydropyridinderivater
EA199900301A2 (ru)	1999-10-28	Замещенные трициклические соединения
DK1200385T3 (da)	2005-05-23	Krystaller af natriumsalt af pravastatin
NO20044369L (no)	1999-05-28	Fremgangsmate for fremstilling av optisk aktive aminoalkoholderivater og deres videre omsetning til (1R,4S)-4-((2-amino-6-klor-5-formamido-4-pyrimidinyl)-amino)-2-cyklopenten-1-metanol
PL361061A1 (pl)	2004-09-20	Postacie krystaliczne fluwastatyny sodowej
DE59307409D1 (de)	1997-10-30	Verfahren zur Herstellung von (3R,5S)6-Hydroxy-3,5-0-isopropyliden-3,5-dihydroxy-hexansäure-tert.-butylester
CO4700282A1 (es)	1998-12-29	Compuestos
EE04345B1 (et)	2004-08-16	Simvastatiini ja selle derivaatide valmistamise protsess
AU1289600A (en)	2000-05-29	Process for racemization
DK1102765T3 (da)	2004-02-02	Fremgangsmåde til syntese af (1H)-benzo[c]quinolizin-3-on-derivater
DK1206452T3 (da)	2005-03-14	Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
NO983511L (no)	1998-09-30	Difenylstilbener som pro-legemidler til COX-2-inhibitorer
DK1165491T3 (da)	2004-06-14	LTA4-hydrolase-inhibitorer
NO306297B1 (no)	1999-10-18	FremgangsmÕte for fremstilling av HIV-proteaseinhibitorer
DK0698111T3 (da)	2003-03-31	Fremgangsmåde til syntese af HMG-CoA-reduktaseinhibitorer
DE69703115D1 (de)	2000-10-19	Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
EA200300400A1 (ru)	2003-10-30	17α-ФТОРАЛКИЛСТЕРОИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
ATE485277T1 (de)	2010-11-15	Verfahren zur herstellung eines 3,5-dihydroxy-6- heptenoats